Chrystian Dallaire

924 total citations
7 papers, 185 citations indexed

About

Chrystian Dallaire is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Chrystian Dallaire has authored 7 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Gastroenterology. Recurrent topics in Chrystian Dallaire's work include Helicobacter pylori-related gastroenterology studies (5 papers), Gastroesophageal reflux and treatments (3 papers) and Gastric Cancer Management and Outcomes (2 papers). Chrystian Dallaire is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (5 papers), Gastroesophageal reflux and treatments (3 papers) and Gastric Cancer Management and Outcomes (2 papers). Chrystian Dallaire collaborates with scholars based in Canada, United Kingdom and Australia. Chrystian Dallaire's co-authors include Jean Spénard, Alain Farley, Carlo A Fallone, Karna Dev Bardhan, Annette Duggan, Françis Mégraud, W. A. De Boer, Thomas J. Borody, Colm O’Morain and J. Piotrowski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Chrystian Dallaire

7 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chrystian Dallaire Canada 7 159 78 74 60 27 7 185
Rudi De Bastiani Italy 7 121 0.8× 35 0.4× 80 1.1× 39 0.7× 18 0.7× 11 163
G. Stoppino Italy 7 234 1.5× 70 0.9× 64 0.9× 129 2.1× 92 3.4× 10 304
L Hyland Australia 4 281 1.8× 110 1.4× 115 1.6× 51 0.8× 22 0.8× 4 303
Liliana Pozzati Spain 3 162 1.0× 77 1.0× 76 1.0× 68 1.1× 14 0.5× 4 170
Н. Н. Дехнич Russia 6 117 0.7× 43 0.6× 64 0.9× 38 0.6× 25 0.9× 27 159
S Brandl Australia 8 420 2.6× 158 2.0× 181 2.4× 74 1.2× 31 1.1× 9 438
Jensen He Denmark 10 204 1.3× 75 1.0× 91 1.2× 18 0.3× 23 0.9× 40 320
O Cannizzaro Italy 7 285 1.8× 121 1.6× 184 2.5× 120 2.0× 16 0.6× 12 339
Carmen Dueñas Spain 5 407 2.6× 42 0.5× 173 2.3× 38 0.6× 60 2.2× 10 481
C. De Giacomo Italy 8 214 1.3× 36 0.5× 115 1.6× 16 0.3× 51 1.9× 19 283

Countries citing papers authored by Chrystian Dallaire

Since Specialization
Citations

This map shows the geographic impact of Chrystian Dallaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chrystian Dallaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chrystian Dallaire more than expected).

Fields of papers citing papers by Chrystian Dallaire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chrystian Dallaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chrystian Dallaire. The network helps show where Chrystian Dallaire may publish in the future.

Co-authorship network of co-authors of Chrystian Dallaire

This figure shows the co-authorship network connecting the top 25 collaborators of Chrystian Dallaire. A scholar is included among the top collaborators of Chrystian Dallaire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chrystian Dallaire. Chrystian Dallaire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Lamet, Mark, et al.. (2005). Efficacy and Safety of Mesalamine 1 g HS Versus 500 mg BID Suppositories in Mild to Moderate Ulcerative Proctitis: A Multicenter Randomized Study. Inflammatory Bowel Diseases. 11(7). 625–630. 19 indexed citations
2.
O’Morain, Colm, Thomas J. Borody, Alain Farley, et al.. (2003). Efficacy and safety of single‐triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study. Alimentary Pharmacology & Therapeutics. 17(3). 415–420. 80 indexed citations
3.
Zanten, Sander Veldhuyzen van, Naoki Chiba, Alan Barkun, et al.. (2003). A Randomized Trial Comparing Seven-Day Ranitidine Bismuth Citrate and Clarithromycin Dual Therapy to Seven-Day Omeprazole, Clarithromycin and Amoxicillin Triple Therapy for the Eradication ofHelicobacter pylori. SHILAP Revista de lepidopterología. 17(9). 533–538. 6 indexed citations
4.
Lahaie, Raymond, Alain Farley, Chrystian Dallaire, et al.. (2001). Bismuth-Based Quadruple Therapy with Bismuth Subcitrate, Metronidazole, Tetracycline and Omeprazole in the Eradication ofHelicobacter pylori. SHILAP Revista de lepidopterología. 15(9). 581–585. 21 indexed citations
5.
Bardhan, Karna Dev, et al.. (1997). Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. Gut. 41(2). 181–186. 31 indexed citations
6.
Rioux, Michel, Audrey Asselin, Roger Grégoire, & Chrystian Dallaire. (1995). Delayed peritoneal and retroperitoneal abcesses caused by spilled gallstones: a complication following laparoscopic cholecystectomy. Abdominal Imaging. 20(3). 219–221. 14 indexed citations
7.
Dallaire, Chrystian, et al.. (1995). GR122311X (ranitidine bismuth citrate) with clarithromycin for the treatment of duodenal ulcer. Gastroenterology. 108(4). A53–A53. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026